跳至主要内容
临床试验/NCT06091813
NCT06091813已完成不适用

Ambrosia: Evaluating the Effects of a Food-As-Medicine Platform on Gut Microbiome Composition and Metabolism

Persephone Biosciences1 个研究点 分布在 1 个国家目标入组 546 人开始时间: 2023年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
546
试验地点
1
主要终点
Nutrition Counseling Microbiome Impact

研究概览

简要总结

The objective of this study is to test whether dietary behavior modification impacts diet quality and stool microbiome composition and metabolism using microbial whole genome sequencing, targeted metabolomics, and immune profiling.

400 adults 18-64 years old at high risk for CRC (based on past colonoscopy findings or lifestyle risk factors) will be assigned to one of two cohorts, with approximately 200 participants in each.

  • Cohort 1 will serve as the control group without any directed dietary modifications.
  • Cohort 2 participants will receive medical nutrition therapy (MNT) via 5 Telenutrition (TN) visits with a registered dietitian (RD), utilizing the Academy of Nutrition and Dietetics' Nutrition Care Process.

Stool samples will be obtained for each subject at baseline and end of study. Whole genome sequencing, metabolite analysis, and immune profiling will be performed on the samples. Demographic data, general health information, diet and lifestyle information will be collected from the subjects (all self-reported). When applicable, notes from telenutrition appointments will also be collected. Diet information will be collected using the Picture Your Plate(TM) validated food questionnaire.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adults 18 to 64 years old at the time of enrollment at high risk for colorectal cancer, defined as follows:
  • •EITHER a personal history of colorectal cancer, advanced adenoma, or 3 or more non-advanced adenomas in a single screening
  • •OR TWO of the following criteria:
  • •One or more first-degree relatives with a history of colorectal cancer
  • •Body mass index above 30 (Persephone will calculate given height and weight
  • •Have smoked an average of 5 or more cigarettes (1/4 pack) per day for a continuous period of 10 years or more.
  • •Able to provide stool samples at study start and after approximately 5 months
  • •Willing and able to undergo virtual Medical Nutrition Therapy based on cohort assignment
  • •Willing to complete online questionnaires concerning diet and lifestyle, in English
  • •Competency in spoken and written English
  • •Can provide written informed consent

排除标准

  • •Subjects with known HIV, Hepatitis A, Hepatitis B, Hepatitis C
  • •Known Familial Adenomatous Polyposis or Lynch Syndrome (aka Hereditary Non-Polyposis Colorectal Cancer or HNPCC) diagnosis
  • •A history of Crohn's Disease, Inflammatory Bowel Disease, or chronic colitis.
  • •Active cancer in the past 2 years, or currently undergoing any form of cancer therapy.
  • •Confirmed case of COVID-19 or influenza within one month prior to enrollment
  • •Oral or systemic antibiotic or probiotic use, or a known GI infection, within 3 months prior to enrollment
  • •Engaged in a nutritional or dietary intervention in the past 3 months.
  • •Women who are pregnant or plan to become pregnant in the next 6 months, or currently nursing.

研究组 & 干预措施

No Directed Dietary Intervention

No Intervention

Control group without any directed dietary modifications

Medical Nutrition Therapy

Experimental

干预措施: Nutrition Counseling (Behavioral)

结局指标

主要结局

Nutrition Counseling Microbiome Impact

时间窗: 4 months

Measure microbiome composition before and after 5 telenutrition visits by whole genome sequencing, and determine change in microbial composition as indicated by gUnifrac distance between the two datapoints.

次要结局

未报告次要终点

研究者

发起方
Persephone Biosciences
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Ambrosia: Evaluating the Effects of a... | 临床试验